AYJ.F
Stock Details
AYJ.F is Valneva SE's stock. Stock exchange Frankfurt (Currency EUR). Average price in 50 days is 3.6679€. Average daily volumn in 3 months 8.35k. Market cap 553.83M
Stock symbol : AYJ.F. Exchange : Frankfurt. Currency : EUR Lastest price : 3.9800€. Total volume : 3.14k. Market state PREPRE Click reload if you want to check the lastest price on market!!!
Valneva SE (AYJ.F)
Last Price
3.9800€Change
0.0440Volume
3.14k
| Previous Close | 3.9360 |
| Open | 3.9520 |
| Day Range | 3.9520-4.1800 |
| Bid | 3.9540 x 250k |
| Ask | 4.0040 x 250k |
| Volume | 3.14k |
| Average Volume | 8.35k |
| Market Cap | 553.83M |
| Beta | 0.84 |
| 52 Week Range | 2.9750-7.8780 |
| Trailing P/E | N/A |
| Foward P/E | N/A |
| Dividend (Yield %) | N/A |
| Ex-Dividend Date | N/A |
Financial Details
Organization
Valneva SE, a specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs. It offers IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera and/or heat-labile toxin producing enterotoxigenic Escherichia coli bacterium; IXCHIQ, a single-dose, live-attenuated... vaccine for the prevention of disease caused by chikungunya virus; and VLA2001, an inactivated whole-virus COVID-19 vaccine. The company also develops VLA15, a vaccine candidate, which is in Phase III clinical trial against Borrelia, the bacterium that causes Lyme disease; VLA1553, a vaccine candidate, which is in Phase III clinical trial against the chikungunya virus; VLA1554, a vaccine candidate targeting human metapneumovirus; and VLA2112, a vaccine candidate to treat patients with epstein-barr virus. It sells its products in the United States, Canada, Germany, Austria, Nordics, the United Kingdom, France, rest of European countries, and internationally. Valneva SE has collaborations with Pfizer, Inc. to co-develop and commercialize its Lyme disease vaccine; and Instituto Butantan for the development, manufacturing, and marketing of single-shot chikungunya vaccine. The company was founded in 1998 and is based in Saint-Herblain, France.
Market Cap:
553.83MRevenue:
153.71M
News about "Valneva SE"
Valneva SE (VALN)
Source from : Yahoo Finance - 4 days ago
Results Intended to Support Filing for Potential Label Extension for Use in Adolescents Saint-Herblain (France), May 13, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty ...See details»
Valneva Appoints Dr. Hanneke Schuitemaker, Ph.D. as Chief Scientific Officer
Source from : Business Insider - 8 days ago
Saint-Herblain (France), May 21, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced the appointment of Dr. Hanneke Schuitemaker, Ph.D. as Chief ...See details»
Valneva SE (INRLF)
Source from : Yahoo Finance - 8 days ago
Results Intended to Support Filing for Potential Label Extension for Use in Adolescents Saint-Herblain (France), May 13, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty ...See details»
Valneva SE Sponsored ADR
Source from : CNN - 5 month ago
Valneva SE is a specialty vaccine company, which focuses on the development, manufacturing, and commercialization of prophylactic vaccines for infectious diseases. It operates through the ...See details»
Valneva reports Q1 results
Source from : MSN - 22 days ago
Valneva generated a net profit of €58.9 million Valneva SE (VALN) Q4 2023 Earnings Call Transcript Valneva GAAP EPS of -€0.73, revenue of €153.71M; updates FY24 guidance Valneva reports FY ...
Valneva SE (VALN) Earnings Dates & Reports
Source from : Investing - 3 years ago
View upcoming earnings forecasts and in-depth analysis of company forecasts.See details»
Valneva SE (VALN) Interactive Stock Chart - Yahoo Finance
Source from : Yahoo Finance - 6 month ago
Results Intended to Support Filing for Potential Label Extension for Use in Adolescents Saint-Herblain (France), May 13, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine ...See details»
Valneva Reports Further Positive Pivotal Phase 3 Data in Adolescents for its Single-Shot Chikungunya Vaccine
Source from : Finanznachrichten - 16 days ago
Results Intended to Support Filing for Potential Label Extension for Use in Adolescents Saint-Herblain (France), May 13, 2024 - Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine ...See details»
Valneva SE American Depositary Shares (VALN)
Source from : Nasdaq - 3 years ago
Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on ...See details»
Valneva Stock (NASDAQ:VALN), Quotes and News Summary
Source from : Benzinga.com - 3 years ago
Valneva Seeks Expanded Use For Its Chikungunya Vaccine In Adolescents With Encouraging Phase 3 Data Valneva released positive Phase 3 data for its single-shot chikungunya virus vaccine in ...See details»
Valneva Reports First Quarter 2024 Financial Results and Provides Corporate Updates
Source from : Yahoo Finance - 22 days ago
Significantly extended cash runway with recent update of debt financing agreement 2 Substantially lower cash burn expected in 2024 as Valneva expects to complete its cost contributions for the Lyme ...See details»
vivo V30 SE
Source from : GSM Arena - 28 days ago
4G bands 1, 2, 3, 4, 5, 7, 8, 12, 13, 17, 18, 19, 20, 26, 28, 32, 38, 40, 41, 66 5G bands 1, 2, 3, 5, 7, 8, 20, 26, 28, 38, 40, 41, 66, 75, 77, 78 SA/NSA ...See details»
Best Apple iPhone SE Case for 2024
Source from : CNET - 26 days ago
Executive Editor David Carnoy has been a leading member of CNET's Reviews team since 2000. He covers the gamut of gadgets and is a notable reviewer of mobile accessories and portable audio ...See details»
2027 Mini Cooper Electric
Source from : Car and Driver - 1 year ago
Two different versions will be offered globally: the 184-hp Cooper E and the 218-hp Cooper SE. However, it's unclear whether both will come to North America. Mini has also drawn inspiration from ...See details»